Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - procaine penicillin - unknown - procaine penicillin antibiotic-penicillin active 0.0 - active constituent

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - procaine penicillin - unknown - procaine penicillin antibiotic-penicillin active 0.0 - active constituent

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - procaine benzylpenicillin, quantity: 1.5 g - injection, suspension - excipient ingredients: sodium citrate dihydrate; water for injections; polysorbate 80 - indications as at 18 february 2002: treatment of moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests and also by clinical response. infections which usually respond to adequate dosage are: group a streptococcal infections including upper respiratory tract infections, skin and skin structure infections and scarlet fever; pneumococcal infections of the respiratory tract; susceptible staphylococcal infections, most gonococcal infections, syphilis, fusospirochaetosis (vincent's gingivitis and pharyngitis). cilicaine syringe 1.5 must be administered by the intramuscular route only (see section 4.2 dose and method of administration).

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bausch + lomb ireland - oxybuprocaine hydrochloride 4 mg/ml - eq. oxybuprocaine 3,58 mg/ml - eye drops, solution - 4 mg/ml - oxybuprocaine hydrochloride 4 mg/ml - oxybuprocaine

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires théa - oxybuprocaine hydrochloride 1,6 mg/0,4 ml - eye drops, solution - 0,4 % - oxybuprocaine hydrochloride 4 mg/ml - oxybuprocaine

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - nafcillin ; benzylpenicillin procaine 300 mg/3 g; dihydrostreptomycin sulfate 100 mg/3 g - intramammary suspension - 100 mg - 300.000 u - 100 mg - dihydrostreptomycin sulfate 100 mg; nafcillin sodium 100 mg; benzylpenicillin procaine 300000 iu - benzylpenicillin - cattle

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bausch + lomb ireland limited - oxybuprocaine hydrochloride - eye drops, solution - local anesthetics; oxybuprocaine

Kenya - İngilizce - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875 nairobi kenya. plot no. 209/10349 - procaine penicillin and benzylpenicillin (as… - powder for injection - procaine penicillin 3000000 i.u and… - combinations

Kenya - İngilizce - Pharmacy and Poisons Board

ray pharmaceuticals ltd p.o. box 22830-00400 nairobi - procaine penicillin bp & benzyl penicillin sodium… - powder for injection - procaine penicillin b.p 3000000iu & benzyl… - beta-lactamantibacterials:

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - benzathine benzylpenicillin tetrahydrate, quantity: 600000 usp unit - injection, suspension - excipient ingredients: carmellose sodium; lecithin; methyl hydroxybenzoate; povidone; propyl hydroxybenzoate; sodium citrate; water for injections - intramuscular benzathine benzylpenicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular benzathine benzylpenicillin: streptococcal infections (group a - without bacteraemia). mild-to-moderate infections of the upper respiratory tract (e.g., pharyngitis). venereal infections - syphilis, yaws, bejel and pinta. medical conditions in which benzathine benzylpenicillin therapy is indicated as prophylaxis: rheumatic fever and/or chorea - prophylaxis with benzathine benzylpenicillin has proven effective in preventing recurrence of these conditions. it has also been used as follow-up prophylactic therapy for rheumatic heart disease and acute glomerulonephritis.